Analysis: A Procedure That Cost $1,775 in New York Was $350 in Maryland. Here’s Why.
The state’s unique health system controls what hospitals can charge for services.
The Checkup Is in the Mail? Soliciting Letter Carriers to Help Deliver Health Care
Here’s an out-of-the-box idea: Have letter carriers spend less time delivering mail and take time to perform home visits and basic health checks on the growing population of frail and elderly.
Análisis: ¿No quieres una vacuna? Prepárate para pagar más por tu seguro de salud
A pesar de que las compañías de seguros negocian precios más bajos y cubren gran parte del costo de la atención, los costos asociados al tratamiento de covid deberían ser un incentivo bastante aterrador.
Analysis: Don’t Want a Vaccine? Be Prepared to Pay More for Insurance.
Health insurers could do more to encourage vaccination, including letting the unvaccinated foot their bills.
Analysis: Necessary or Not, Covid Booster Shots Are Probably on the Horizon
In today’s pharmaceutical universe, a simple “safe and effective” determination by the Food and Drug Administration to approve a drug can be manipulated to sell products of questionable value. And drugmakers can profit handsomely.
Why We May Never Know Whether the $56,000-a-Year Alzheimer’s Drug Actually Works
It could take years for follow-up studies to prove Aduhelm slows the disease — or doesn’t. Meanwhile, its maker will profit.
Analysis: Why We’ll Likely Never Know Whether a Covid Lab Leak Happened in China
If international scientific sleuths are hoping to see a lab log or find a whistleblower, that sort of information won’t be revealed. In China today, it is dangerous to say what you know if it challenges the official government narrative.
Telemedicine Is a Tool — Not a Replacement for Your Doctor’s Touch
The pandemic has demonstrated that virtual medicine is great for simple visits. But many new types of telemedicine promoted by start-ups more clearly benefit providers’ and investors’ pockets, rather than yielding more convenient, high-quality and cost-effective medicine for patients.
Analysis: I Was a Teenage Rifle Owner, Then an ER Doctor. Assault Weapons Shouldn’t Count as ‘Guns.’
The United States has undergone a cultural, definitional, practical shift on guns and what they are for.
Analysis: How the US Invested in the War on Terrorism at the Cost of Public Health
After 9/11, as our defenses against international and bioterrorism hardened, our defenses against infectious diseases shrank. By the time a deadly virus arrived on our shores last year, nearly two-thirds of Americans were living in counties that spend more than twice as much on policing as they spend on public health.
Analysis: The Trump Health Care Policies That Deserve to Stick Around
President Joe Biden may want to continue the previous administration’s efforts to lower drug prices and make medical costs transparent.
Beijing’s SARS Lockdown Taught My Children Resilience. Your Covid Kids Will Likely Be Fine.
Living through SARS taught my children important lessons, and not just about hygiene. It taught them how to make sacrifices for the sake of friends, family and community.
With Demand Far Exceeding Supply, It Matters That People Are Jumping the Vaccine Line
When hospital administrators and politicians’ spouses get immunized before people more at risk, it undermines confidence in the system.
Analysis: Some Said the Vaccine Rollout Would Be a ‘Nightmare.’ They Were Right.
There are already signs that the distribution of the COVID vaccines will be messy, confusing and chaotic.
It’s Time to Scare People About COVID
Our public messaging about the virus should explain the real costs — in graphic terms — of catching the virus.
Voz de un experto: los niveles de seguridad que propone Fauci durante COVID
El doctor Anthony Fauci, la autoridad máxima en enfermedades infecciosas del país, dice que, si la mayoría de las personas se vacuna, se lograría cierta “normalidad” a mediados de 2021.
Take It From an Expert: Fauci’s Hierarchy of Safety During COVID
In a new interview, the nation’s top infectious disease expert tells us how to survive the coming months and describes how hard it is when people still insist the coronavirus outbreak is “fake news.”
Análisis: el invierno llega para los bares. Cómo salvarlos. Y salvarnos.
Son lugares de alto riesgo de propagación. ¿Por qué no compensar a los propietarios para que cierren sus negocios para proteger la salud pública?
Analysis: Winter Is Coming for Bars. Here’s How to Save Them. And Us.
To stop the coronavirus, we need to stop super-spreader events.
Analysis: ‘Don’t Be Afraid of COVID’? Not Buying It, Unless Businesses Do Job Right
COVID precautions may seem like overkill. But I won’t set foot in a store unless certain steps are taken.
